Illustration: Gabriella Turrisi/Axios
Medeloop, a General Catalyst-backed life science research startup, raised a $15 million Series A to help accelerate medical research, CEO Rene Caissie tells Axios exclusively.
Why it matters: R&D costs for a new drug range from $314 million to $4.46 billion.